chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the beginning of May, I developed mouth ulcers and they were along my cheeks,  under my tongue,  and down the inner side of my lips. On the top part of my mouth,  it felt like it was swollen, the fat part of the sides of my tongue  were swollen on either sides. I would have to be careful not to bite my tongue. My mouth got real dry. I bought stuff from the pharmacy for dry tongue. That lasted 6 weeks before it completely  went away.  In June I saw NP, she said it was mouth ulcers and she told me to rinse my mouth a couple of times a day with Mylanta for the pain and that it would start healing. She said there wasn't very much they could do for it.
Getting COVID-19 after receiving the first dose of Moderna COVID-19 vaccine; Feels really weak two weeks after contracting COVID -19 infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting COVID-19 after receiving the first dose of Moderna COVID-19 vaccine) and ASTHENIA (Feels really weak two weeks after contracting COVID -19 infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting COVID-19 after receiving the first dose of Moderna COVID-19 vaccine) and ASTHENIA (Feels really weak two weeks after contracting COVID -19 infection). At the time of the report, COVID-19 (Getting COVID-19 after receiving the first dose of Moderna COVID-19 vaccine) and ASTHENIA (Feels really weak two weeks after contracting COVID -19 infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.
Experienced constant joint pain following the COVID-19 Vaccines and subsequently diagnosed with Juvenile Rheumatoid Arthritis by Hospital.
Information has been received from a physician concerning a female who was vaccinated intramuscularly with Gardasil.  It was not known if this was the first, second or third dose.  Subsequently the patient felt dizzy and had to be kept in the examination room for 25 minutes until she recovered.  The patient sought unspecified medical attention.  Per the reporter, the patient has had the same reaction to other vaccines, but the identity of those vaccines was unknown.  Additional information has been requested. 02/10/2010 Follow up information received on B-form (26-FEB-2008): Per the reporter, within a few minutes after receiving the vaccines, the patient complained of feeling faint, hot, nauseous. The patien's color was gray and blood pressure was 110/70. The patient continued to feel weak and dizzy. The physician came to see the patient. The exam was normal and the patient was diagnosed with a syncopal episode post -injection. The patient's blood pressure was 109/72 and pulse was 67. The patient was allowed to rest until the symptoms subsided.  This is in follow-up to report(s) previously submitted on 2/14/2008; 4/7/2008. Information has been received from a physician concerning a 19 year old female with a history of AMOXIL allergy who on 11-JAN-2008 was vaccinated IM with the first dose of GARDASIL (659439/1267U) (duration and dose not reported)(Lot# reported as 1462U). Other concomitant therapy included HAVRIX (GSK) (AHAVB225AA). On 11-JAN-2008 the patient experienced syncopal episode. Subsequently, the patient recovered from syncopal episode.
My wife is having side effects that have to do with the formation of blood clots in the reproductive system.; This is a spontaneous report from a contactable consumer (consumer's wife). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Formulation: solution for injection, Batch/Lot Number and Expiration Date were not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The reporter has been reporting on COVID. His wife and he has been vaccinated. His wife was having side effects that have to do with the formation of blood clots in the reproductive system. Consulted in different forums in two countries there are many women reporting the same. The outcome of event was unknown on an unspecified date.  Information on lot/batch number has been requested.
I had racing heart, Heart beat increased felt like pounding out of my chest. Also I developed a fever and headache.  Symptoms fever 2 days. Heart issue one week and a half.
Mother reports a red rash and hives over her entire body with itching.  Mother denied any respiratory distress.  Mother administered 3 tsp of liquid Benadryl.  Patient slept through the night, awoke the next morning with the rash and hives remaining on the lower extremities.  Mother reports that she administered Liquid Benadryl again on Sat. morning.  Patient reports that she then went to basketball practice and felt fine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 12:00 as dose 4 (booster), single (Lot number: GH9693) at the age of 54 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced treatment of covid-19. Also, tested positive for covid 4 days after finishing paxovid medication. Previously tested negative with now symptoms on day 8 of original covid illness. Rebound symptoms include sore throat, runny nose, headache. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid. Outcome of the events was not recovered.
states the rash is on his back and the back of his legs; first case of shingles; Legs Cramps; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50-year-old male patient received BNT162b2 (BNT162B2), on 04Mar2021 at 10:30 as dose 2, single (Lot number: EN6199, Expiration Date: 30Jun2021) at the age of 50 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Covid", start date: Nov2020 (unspecified if ongoing), notes: He states he had contracted Covid in Nov2020; "sleep" (unspecified if ongoing). Concomitant medication(s) included: AMBIEN taken for sleep disorder; CANNABIDIOL taken for sleep disorder; TETRAHYDROCANNABINOLS NOS taken for sleep disorder. Vaccination history included: BNT162b2 (Dose: 1, Time: 10:30, Anatomical Site of injection: Unknown Arm, Route of Administration: Standard Dose Injection into Arm, Batch/Lot number: EN6201), administration date: 11Feb2021, when the patient was 50-year-old, for COVID-19 immunization, reaction(s): "skin rash", "heart problems", "low heart rate", "tachycardia", "sick". The following information was reported: HERPES ZOSTER (non-serious) with onset 06Apr2021, outcome "recovered" (30Apr2021), described as "first case of shingles "; MUSCLE SPASMS (non-serious) with onset Apr2021, outcome "recovered" (Jun2021), described as "Legs Cramps"; RASH (non-serious), outcome "unknown", described as "states the rash is on his back and the back of his legs". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Patient was diagnosed with shingles when he went to a routine appointment at his Rheumatologist on 12Apr2021, but the Shingles started the previous week. The cramps would never stop for 15-20 minutes and he has never had an experience like that before. He stated he thought his leg was going to tear. They lasted several months and they would come and go. Family Medical History Relevant to Adverse Events was none.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201300313 same product, patient, different AEs, different dose.;US-PFIZER INC-202201300370 same product, patient, different AEs, different dose.;
Moderna COVID-19 Vaccine: Metallic taste in mouth after 15 minute wait time. Taste diminished after 30 minutes
Red itchy spot at injection site that was 2in. wide and 4 in. long on the first day it appeared.  on the second day it grew to 2in. wide and 6 in. long. As i am writing this, today, which is the third day after it appeared, the area is barely visible.  took Benadryl for two days for treatment.  I also notified my physicians office, but as of this morning, i have not heard back from them.
Large raised red warm-to-touch area, at injection site, mildly tender to touch. Not impact on breathing.  Child has received influenza vaccines yearly since birth with no previous reaction, as had all siblings.  Strangely this child and all siblings reacted in the same way to this vaccination. Concerned about issues with the product lot.
Episodes of lightheadedness and nausea from Jan 17-21, 2021. Kept bp cuff on so I could measure bp at time of episode. Bp normally about 120/75, but during episodes bp would drop to numbers like 85/60. Within a couple minutes of episode, bp would return to normal.
3 Pts each vax w/series of 3 hep B; all had titers of less than 10 p/last inject;
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided.  Reporter also stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.  Reporter stated that no treatment was given to patients.
Started with itchiness of hands and feet.  The next couple of days it was itchiness and hives in crotch area.  A couple of days later it was angioedema of lips.  Antihistamine (Claritin) helps reverse reaction but if I do not take the antihistamine every 36-48 hours I start to get hives on torso/crotch and can feel the angioedema swelling to start in my lips.  No problem with tongue, throat or stomach swelling.  Have tried all sorts of different diet changes to ensure it is not a food allergy, but everything points toward the flu shot that contained A, B & H1N1.  I have gotten the flu shot for A and B for at least a decade, so that is not the problem.
A male patient alleges that he received an injection of Flu Shield (1997-1998 Formula) on 01/14/98. Approximately 4 hours post-vaccination, the patient stated that he was "gasping for breath and could hardly walk." He reportedly was seen in an emergency room on 02/20/98 and diagnosed with "double" pneumonia. At that time, the patient reported he was hospitalized and received unspecified treatment. The patient also alleges that as a result of the pneumonia, he has suffered a loss of respiratory capacity requiring daily oxygen use.
Expired Menveo administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 35-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA639A, expiry date 31st October 2022) for prophylaxis.   On 14th December 2022, the patient received Menveo. On 14th December 2022, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 16-Dec-2022 Reporter's comment: The health care professional's details were sent by email to safety because there was no permission too create an account on medical information system. The reporter consented to follow-up by email. Additional supportive information: The patient received an expired dose of Menveo, which led to expired vaccine used.
Patient felt slight shortness of breath, sweats/chills, tingling in the right extremity, mental fog/fatigue, nausea within 10 minutes of being vaccinated with the first dose.  Patient reported not having swelling or tingling in lips/tongue/throat. Patient reported not having much to eat or drink prior to coming in for his vaccine. Called 911 due to patient's complaints and concern about him having a possible allergic response.
Chills; This is a spontaneous report received from contactable reporter(s) (Pharmacist). The reporter is the patient.  A 12-year-old male patient received BNT162b2 (BNT162B2), on 08Jun2022 at 13:00 as dose 3 (booster), single (Lot number: FM9992) at the age of 12 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: QUILLICHEW ER. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: FL0007, Location of injection: Arm Left, Vaccine Administration Time: 11:00 AM), administration date: 11Dec2021, when the patient was 11-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: FK5127, Location of injection: Arm Left, Vaccine Administration Time: 11:00 AM), administration date: 20Nov2021, when the patient was 11-year-old, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 09Jun2022 at 14:00, outcome "unknown". Therapeutic measures were not taken as a result of chills.  Additional information: The patient had no known allergies. The patient did not receive COVID prior vaccination and had not been COVID tested post vaccination. The patient did not receive other vaccine in four weeks.  No follow-up attempts are possible. No further information is expected.
large decrease in his ability to run/now he can only make it 200 Yards before getting tired and fatigued; pain in his legs and they just start to ache while sitting; sore left arm after the injection; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (large decrease in his ability to run/now he can only make it 200 Yards before getting tired and fatigued), PAIN IN EXTREMITY (pain in his legs and they just start to ache while sitting) and VACCINATION SITE PAIN (sore left arm after the injection) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A and 076C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, the patient experienced VACCINATION SITE PAIN (sore left arm after the injection). On an unknown date, the patient experienced FATIGUE (large decrease in his ability to run/now he can only make it 200 Yards before getting tired and fatigued) and PAIN IN EXTREMITY (pain in his legs and they just start to ache while sitting). At the time of the report, FATIGUE (large decrease in his ability to run/now he can only make it 200 Yards before getting tired and fatigued), PAIN IN EXTREMITY (pain in his legs and they just start to ache while sitting) and VACCINATION SITE PAIN (sore left arm after the injection) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Patient developed eczema type break-out all over his body. Patient had been diagnosed this year with eczema. Patient went to his Dermatologist who now treating him with steroids. Patient questions the dry heat in his house as being a probabal cause. He received the flu shot from us on October 3,2003 but this was reported to my office on December 16, 2003. I am reporting this because patients Dermatologist said the flu shot gave him the outbreak.
chest started hurting; throat hurt really, really bad; This is a spontaneous report from a contactable consumer (patient). A 31-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0187 and Expiration Date was not reported) via an unspecified route of administration, administered in Arm Left (near the shoulder) on 18May2021 (at the age of 31-years-old) as SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated that, she took the vaccine on 18May2021 and she was fine. Then starting yesterday (on 31May2021), the patient chest started hurting and throat hurt really, really bad. The patient was supposed to get the second dose on the 08Jun2021 and so the patient wanted to know if she should still get the second dose and should she go to the doctor. The patient stated that, she was going to call her doctor. The outcome of events was unknown.  No further information was provided or obtained.
took a 2 hour nap; felt tired after his second Moderna Covid-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (took a 2 hour nap) and FATIGUE (felt tired after his second Moderna Covid-19 vaccination) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21-2A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (took a 2 hour nap) and FATIGUE (felt tired after his second Moderna Covid-19 vaccination). At the time of the report, SOMNOLENCE (took a 2 hour nap) and FATIGUE (felt tired after his second Moderna Covid-19 vaccination) outcome was unknown.            No concomitant medications were reported   No treatment information was provided
Information has been received from a pharmacist via a company representative referring to an unspecified number of patients (unknown demographics) under 50 years of age. Information about patients' concurrent conditions and medical history was not reported. On unspecified dates these patients received ZOSTAVAX (lot #, dose and route not reported) (inappropriate schedule of vaccine administered). No adverse effects were reported. Additional information has been requested.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 20-OCT-2015, the patient was vaccinated VARIVAX, lot # L015045 (dose, dose number, vaccination site, route, expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from same reporter. Additional information has been requested.
My left arm went numb two days after the second Moderna shot. I had pins and needles sensation on various parts of my arm, hand and all my fingers. My lymph glands in armpit were swollen and tender. I saw my primary care doctor on the 30th April. He diagnosed it as Lumphederma Left upper Extremity. He suggested massage to drain lymph glands. I had a massage two days later. Feeling returned to most of my arm, except for pointer and middle fingers. They remain numb although the pins and needle sensation has disappeared. I repeated massage a month later, with no further improvement or development.
This initial non-serious spontaneous case, was received from other non-health professional on 16-Nov-2017, concerns a female patient of unspecified age. On 09-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (anatomical location: deltoid, dose, route of administration, batch number and expiry date: not reported). It was reported that the patient received flu shot at a clinic, but no fluid was released in the first attempt from Stratis NFIS (Needle-free Injection System). The same result with the second attempt, the Stratis NFIS did not release the vaccine at time of administration. It was reported that the patient felt very strong punch each time she was injected. She was vaccination with a conventional needle/syringe injection, which occurred without incident. On 09-Nov-2017, the patient's arm was bruised and sore at the injection site. The outcome of the events was not reported. Follow up received on 07-Dec-2017: The vaccination date (09-Nov-2017) was updated. It was confirmed that, vaccination was not delivered from Stratis NFIS (Needle-free Injection System). The narrative was amended accordingly.
Developed flu like symptoms, sore throat, joint stiffness, local swelling with redness at injection site at R upper arm and some generalized pruritis.  Symptoms lasted 5 days, possibly 2-3 more days.
High fever 106 night 1, chills, severe cramping on right side (ribs and down whole side) 102 most of next day 3/15 Headache and fatigue 3/15 3/16 no fever, no headache, very sore joints
Headache, myalgia, urticarial pruritus, nausea vomiting and swelling, erythema. Hydroxyzine 25 mg once.
Presented to hospital for increased SoB and weakness. Diagnosed with COVID-19 on 7/8. Discharged home on 2L O2 and dexamethasone. On 7/12 presented again with hypoxia, elevated WBC/ D-dimer. O2 titrated to 5 L NC and transferred to our facility on 7/12.  Oxygen requirement continued to increase and patient admitted to ICU on 7/14. Currently receiving dexamethasone and received tocilizumab 7/13. Received remdesivir initially but was discontinued on transition to HFNC> Currently on HFNC w/NRB 50 L at 90%
Patient got rash all over body.  Treated with Solu-medrol dose pack, Pepcid, Zyrtec, and Prednisone dose pack.
Experienced a fever of 100 degrees about 7.5 hours after injection. The fever lasted for about 9.5 hours. Fever fluctuates between 100 degrees and 102 degrees.
Saturday was red and swollen Redness spreading to the lower arm Arm is painful. Tender to touch